Cargando…
Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
BACKGROUND: Palbociclib is a selective well-tolerated antineoplastic drug used in the treatment of advanced HER2-negative, estrogen-receptor positive breast cancer that has shown significant improvement in progression-free survival. We present a patient that developed severe rhabdomyolysis with tetr...
Autores principales: | Nersesjan, Vardan, Hansen, Klaus, Krag, Thomas, Duno, Morten, Jeppesen, Tina D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806583/ https://www.ncbi.nlm.nih.gov/pubmed/31640597 http://dx.doi.org/10.1186/s12883-019-1490-4 |
Ejemplares similares
-
Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2022) -
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2023) -
Simvastatin: Rhabdomyolysis: case report
Publicado: (2020) -
Severe Rhabdomyolysis Associated with Simvastatin and Role of
Ciprofloxacin and Amlodipine Coadministration
por: De Schryver, Nicolas, et al.
Publicado: (2015) -
Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
por: Nelson, Kellie Lynn, et al.
Publicado: (2017)